Doximity's Q2 results show record engagement and accelerating adoption of AI workflow tools, signaling deeper physician reliance on the platform. Revenue quality is improving as pharma clients shift ...

Doximity delivered strong 2Q26 results, beating EPS and revenue estimates with 23% year-over-year growth, driven by robust adoption of AI-enabled workflow tools. DOCS maintains exceptional ...

Doximity Inc’s stock reached a significant milestone, hitting a 52-week low at 45.96 USD, just slightly below its current price of $45.85. This recent dip underscores a challenging year for the ...

Doximity, Inc. engages in the development and operation of an online platform for medical professionals. Its cloud-based software has the ability to enable users to collaborate with their colleagues, ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. Featuring daily updates ...

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report ...